Behavioral Activation for Depression in Older Adult Cancer Survivors: Pilot Randomized Control Trial and Implementation Outcomes

Project Summary/Abstract: As many as 35% of older adult cancer survivors (OACS; ≥65-years, ≥1-year post- treatment) have clinically significant depression. Presently, 64% of cancer survivors are ≥65-years old, and that number will increase to 73% by the year 2040. Thus, the number of depressed OACS will exceed 6 million as

the U.S. population continues to age. Even if OACS pursue depression treatment, they may not receive developmentally appropriate services because the geriatric mental health workforce is too small to meet the needs of this growing population in oncology. Therefore, OACS are a uniquely high-risk group for untreated

depression in need of novel, widely disseminable treatment strategies. Yet, no studies have evaluated the implementation of evidence-based depression treatment forolder adults through cancer survivorship clinics. The current study adopts an implementation science framework to target depressionin OACS. Dr. Saracino proposes

the adaptation of Behavioral Activation (BA) as a promising, straightforward treatment to increase OACS’ engagement in evidence-based depression treatment. Using an exploratory sequential mixed methods design, including a small open pilot and randomized control trial, this study has three specific aims: 1) To obtain feedback

from key stakeholders (i.e., OACS, social workers, survivorship clinic clinicians) to revise the BA manual content and procedures and develop an understanding of barriers to treatment engagement in OACS; 2) To evaluate implementation outcomes (i.e., appropriateness, acceptability, adoption, feasibility, fidelity, penetration, and

sustainability) of BA in cancer survivorship; and 3) To determine the preliminary effects of BA on depression (primary outcome), anxiety, coping, and behavioral activation (secondary outcomes) compared to a Supportive Psychotherapy (SP) control arm. Completion of this project will facilitate Dr. Saracino’s long term career goal of

becoming an independent investigator with expertise in the dissemination and implementation (D&I) of mental health screening and treatment for older adults across the cancer trajectory. In the context of a supportive, enriching environment with a strong mentorship team of national and international experts, Dr. Saracino will

continue to acquire advanced training in 5 areas critical to her success as an independent investigator: 1) Cancer Survivorship; 2) Geriatric Mental Health Research; 3) D&I Science; 4) Mixed Methods; and 5) Longitudinal Data Analysis. Dr. Saracino is completing a comprehensive 5-year training plan that includes guided mentoring, formal

coursework, seminars, online trainings, national conferences, and hands-on research activities that directly parallel her training goals. This supplement and detailed plans for return to full productivity after maternity leave will allow Dr. Saracino to continue to work towards becoming an independent investigator with R01 funding with

minimal disruption.